Amphastar Pharmaceuticals Inc vs Lamb Weston Holdings Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Lamb Weston Holdings Inc trades at $52.79 (market cap $7.23B). The key difference: Lamb Weston Holdings Inc is far larger — about 8.3× Amphastar Pharmaceuticals Inc's market cap, and Lamb Weston Holdings Inc pays a 2.89% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | LW | |
|---|---|---|
Market Cap | $868.62M | $7.23B |
Sector | Health | Consumer Staples |
52-Week High | $30.81 | $66.57 |
52-Week Low | $16.87 | $38.48 |
Enterprise Value | $1.27B | $11.10B |
Dividend Yield | — | 2.89% |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →